In the present study we examined in more detail the dual role of the c-JUN N-terminal kinase (JNK) and p38 stress-activated protein kinase pathways in mediating apoptosis or cellular activation in hematopoietic cells. Growth factor deprivation of the erythroleukemic cell line TF-1 led to apoptosis which was associated with an enhanced activity of JNK and p38 and immediate dephosphorylation of the extracellular signal-regulated kinases (ERKs). Enhanced activity of p38 and JNK was not only observed during apoptosis but also in TF-1 cells stimulated with IL-1. IL-1 rescued TF-1 cells from apoptosis. In this case, the upregulation of p38 and JNK was associated with an enhanced activity of ERK. By using SB203580, a specific inhibitor of the p38 signaling pathway, it was demonstrated that p38 plays a pivotal role in the apoptotic process. SB203580 repressed the apoptotic process to a large extent. In contrast, PD98059, a specific inhibitor of the ERK pathway, counteracted the suppressive effects of SB203580 and IL-1 on the apoptotic process indicating that the protective effect of SB203580 and IL-1 might be the result of a shift in the balance between the ERK1/2 and p38/JNK route. This was also supported by experiments with TF-1 cells overexpressing the Shc protein that demonstrated a significantly lower percentage of apoptotic cells, which coincided with higher ERK activity. Finally, the IL-1 and SB203580-mediated effects were associated with an enhanced nuclear factor-B (NF-B) and activator protein-1 (AP-1) binding activity, which could also be blocked by PD98059. These data demonstrate a dual function of the p38 pathway whereby other factors, such as ERK kinases, AP-1 and NF-B, might determine the final cellular response.
Introduction
Binding of cytokines to their cognate receptors triggers activation of different signal transduction cascades of which the MAPK family is of great relevance. Two different groups of MAP kinases have been identified so far; the extracellular signal-regulated kinases (ERK1 and ERK2), and the stress-activated protein kinases (SAPKs). [1] [2] [3] [4] [5] [6] [7] Three members belong to the group of the SAPKs, SAPK1 (also termed c-JUN NH 2 -terminal kinase (JNK)), SAPK2 (also termed p38, RK and Mxi2) and the recently identified SAPK3 (also termed ERK6). [8] [9] [10] [11] [12] In cell lines the activation of the ERK pathway by growth factors and cytokines is mostly associated with proliferation and differentiation. 2, 6, 13, 14 On the other hand, cellular stress and cell activation by cytokines like interleukin-1 (IL-1), IL-3, and tumor necrosis factor ␣ (TNF␣) is associated with an enhanced activity of the JNK, p38 and SAPK3 kinases, resulting in the activation of the downstream transcription factors c-JUN, ATF-2 and NF-B. [15] [16] [17] [18] [19] [20] [21] [22] [23] However, the JNK/p38 pathway is not only involved in cell activation but also plays a pivotal role in apoptosis. 24, 25 Neuronal cells deprived of nerve growth factor (NGF) showed an enhanced activity of JNK/p38 and decreased activity of ERK1/2, suggesting a link between apoptosis and JNK/p38 activity. 24 Furthermore, it has been suggested that the balance between the growth factor-activated ERK and stress-activated JNK/p38 pathways is important in determining whether a cell survives or undergoes apoptosis. 24 The signal transduction pathways leading to apoptosis have not been completely elucidated yet. Recently, involvement of caspase proteases has been implicated in apoptosis. [26] [27] [28] [29] Several studies reported that caspases can function both upstream and downstream of the JNK signaling pathway in the induction of apoptosis. In anoikis, apoptosis induced by contactloss with the extracellular matrix, the upstream activator of JNK, MEKK-1, was activated by caspase cleavage which in turn induced more caspase activity. 26 In addition, a role for interleukin-1␤ converting enzyme (ICE) protease acting upstream of p38 has been suggested in Fas-induced apoptosis. 30, 31 These data demonstrate a dual function of the p38 pathway in cell activation and apoptosis whereby other factors might determine the final cellular response. In the present study we examined in more detail the dual role of the JNK and p38 pathways in hematopoietic cells in mediating apoptosis or cellular activation. The results demonstrate an enhanced activity of JNK and p38 in TF-1 human erythroleukemia cells undergoing apoptosis due to growth factor deprivation which coincided with an immediate decrease of ERK kinase activities and downregulation of the binding activity of the transcription factors NF-B and AP-1. We provide evidence that also in hematopoietic cells p38 plays a pivotal role in apoptosis since the p38 inhibitor SB203580 prevented apoptosis to a great extent. Furthermore, we show that IL-1 serves as a survival factor for the TF-1 cell line, since exposure to IL-1 resulted in enhanced cell survival which coincided with p38 and ERK activation and NF-B upregulation.
Materials and methods

Materials
RPMI 1640 medium was purchased from Flow (Rockville, MD, USA) and fetal bovine serum (FBS) from Hyclone (Logan, UT, USA). IL 1␤ was obtained from Boehringer (Mannheim, Germany) and IL-3 was a gift from Dr SC Clark (Genetics Institute, Cambridge, MA, USA). Phorbol Myristate Acetate (PMA) and Myelin Basic Protein (MBP) were obtained from Sigma (St Louis, MO, USA) and Anisomycine from Biomol (Plymouth Meeting, PA, USA). Radio-nucleotides were obtained from Amersham (Buckinghamshire, UK). Antibodies against ERK1, JNK1, p38 and SHC were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody against actin was obtained from Boehringer. The MEK1 inhibitor PD98059 was purchased from New England Biolabs (Beverly, MA, USA) and the p38 inhibitor SB203580 was kindly provided by Dr JC Lee (SmithKline Beecham Pharmaceuticals, King of Prussia, PA, USA). 32 The plasmid for GST-ATF-2 was a generous gift from Dr H van Dam (Department of Molecular Carcinogenesis, University of Leiden, The Netherlands) and the GST-c-Jun construct was kindly provided by Dr J Borst (The Netherlands Cancer Institute, Amsterdam, The Netherlands).
Cell culture
The human erythroleukemia cell line TF-1 was cultured in RPMI 1640 supplemented with 5% FBS and 10 ng/ml IL-3. TF-1 SHC and TF-1 SN cell lines were a generous gift from L Lanfrancone (University of Perugia, Italy). The Shc-overexpressing (TF-1-SHC) and control (TF-1-SN) TF-1 cells were prepared by retrovirus-mediated gene transfer as previously described 33 and cultured in 5% FBS and 10 ng/ml IL-3.
Western blotting
The amount of p38, JNK, ERK, SHC and actin protein was determined by Western blot analysis. Therefore, cells were cultured at a density of 1 × 10 6 cells/ml in normal growth medium or in RPMI 1640 medium supplemented with 0.1% FBS for 15 min, 2, 6, 16, 24 or 48 h. 15 × 10 6 cells were harvested and lysed in 400 l lysis buffer (20 mM HEPES pH 7.4, 2 mM EGTA, 50 mM ␤-glycero-phosphate, 1 mM DTT, 1 mM Na 3 VO 4 , 1% Triton-X100, 10% glycerol, 10 g/ml leupeptin and 0.4 mM PMSF) for 15 min on ice. After 10 min centrifugation at 3000 g (4°C), the supernatants were normalized for protein content. 5 × SDS sample buffer was added to equal amounts of protein, the samples were boiled for 5 min and proteins were fractionated by running them on a 12.5% SDS-PAGE gel (acrylamide:bisacrylamide, 30:0.8). The proteins were electrophoretically transferred to PVDF membrane (Millipore, Bedford, MA, USA) and probed with polyclonal antibodies to p38, JNK, ERK or SHC or monoclonal antibody to actin (1:4000 dilution). Immunocomplexes were detected using enhanced chemiluminescence (ECL; Amersham).
Bacterial expression of GST-fusion proteins
Glutathione S-transferase (GST) fusion proteins were expressed in Escherichia coli. The pGEX2-ATF-2 and pGEXc-Jun plasmids were transformed into the E. coli strain DH5␣. Overexpression of the proteins was induced with 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). The cells were pelleted, resuspended in NETN buffer (20 mM Tris-HCI pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.4 mM PMSF, 10 g/ml leupeptin) and lysed by sonication. The fusion proteins were isolated by adding glutathione-Sepharose beads to the supernatant. After rotating the lysates for 30 min at 4°C the conjugates were washed three times in NETN buffer. The GST-fusion proteins were eluted from the beads by incubating them with 5 mM reduced glutathione Sepharose in 50 mM Tris-HCI pH 8.0.
In vitro kinase assays
JNK, p38 and ERK kinase activities were determined by the ability of these enzymes to phosphorylate their respective substrates c-Jun, ATF-2 and MBP in the presence of ␥-
32
-P-ATP. Cells were cultured overnight in RPMI 1640 with 0.1% FBS at a density of 1 × 10 6 cells/ml and the next day stimulated for 15 min with either IL-1 (100 U/ml) with or without SB203580 (1 M) or PD98059 (10 M), PMA (50 ng/ml) or anisomycin (10 g/ml). For the growth factor deprivation experiments cells were cultured in normal growth medium or in RPMI 1640 medium supplemented with 0.1% FBS for 15 min, 2, 6, 16, 24 or 48 h. 15 × 10 6 cells were harvested and lysed in 400 l lysis buffer (20 mM HEPES pH 7.4, 2 mM EGTA, 50 mM ␤-glycero-phosphate, 1 mM DTT, 1 mM Na 3 VO 4 1% Triton-X100, 10% glycerol, 10 g/ml leupeptin and 0.4 mM PMSF) for 15 min on ice. After 10 min centrifugation at 3000 g (4°C), the supernatants were normalized for protein content and incubated with 4 l anti-JNK, anti-p38 or anti-ERK in a total volume of 500 l for 30 min at 4°C. Twenty-five l of a slurry of 50% Protein A Sepharose beads was added to the lysate/antibody mixture and left rotating overnight at 4°C. Subsequently, the antibody/beads conjugate was washed three times with lysis buffer, twice with LiCl buffer (500 mM LiCl, 100 mM Tris-Cl pH 7.6, 0.1% Triton-X100 and 1 mM DTT) and finally three times with buffer A (20 mM MOPS pH 7.2, 2 mM EGTA, 10 mM MgCl 2 , 1 mM DTT and 0.1% Triton-X100). After the supernatant was completely removed, the reaction was initiated by adding 50 l of reaction mix (43.5 l buffer A, 20 mM MgCl 2 , 25 M ATP, 7.0 g GST-c-Jun, GST-ATF-2 or 7.5 g MBP and 10 Ci ␥-32 P-ATP) and incubation took place at 30°C for 20 min. The reaction was terminated by addition of 15 l SDS-sample buffer (4×). Before examining the phosphorylation of the substrate proteins by SDS-PAGE, the samples were boiled for 5 min. Molecular weight marker (Amersham) was used to asses the correct protein size. After running, the gel was washed in water for 15 min, twice in 5% TCA/1% Na 2 pyrophosphate for 2 h and once in water. Gels were dried and phosphorylated proteins were visualized by autoradiography and quantified by Phosphor Imaging (Molecular Dynamics, Sunnyvale, CA, USA).
Electrophoretic mobility shift assay
Cells were cultured for 48 h in normal growth medium, in RPMI 1640 medium supplemented with 0.1% FBS with or without IL-1 (100 U/ml), SB203580 (1 M), or PD98059 (10 M). Nuclear extracts were prepared according to the mini-scale procedure as previously described, 34 divided in small aliquots and stored at −80°C.
Double-stranded synthetic oligonucleotide probes containing the NF-B and AP-1 consensus sequences of the IL-6 promotor (NF-B: 5Ј-AGCTGCGGGATTTTCCCTG-3Ј, AP-1: 5Ј-AGCTCGCGTGACTCAGCTG-3Ј) were used in the gel retardation assay. Fifty ng of HPLC-purified single-stranded oligonucleotide was labeled with T4-polynucleotide kinase and ␥ 32 P-ATP (3000 Ci/mmol, Amersham), separated from non-incorporated radiolabel by sephadex G50 chromatography, ethanol precipitated, dried, and dissolved in 20 l of 10 mM Tris-HCI pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA and 1 mM DTT, containing a four-fold excess of the opposite strand. Annealing of the two strands was performed by heating the mixture for 2 min at 90°C and slow cooling to room temperature. Five g nuclear extract and 0.1 ng double-stranded labeled oligonucleotide were incubated in 20 mM HEPES pH 7.9, 60 mM KCl, 0.06 mM EDTA, 0.6 mM DTT, 2 mM supermidine, 10% glycerol, supplemented with 2 g poly (dl-dC). The binding reaction was performed at 26°C for 25 min.
Competition experiments were performed by adding a 100-fold molar excess of unlabeled self or non-self doublestranded oligonucleotides. Supershift experiments were performed by incubating the nuclear extracts with polyclonal antibodies against the p50 and p65 subunits of NF-B (Santa Cruz Biotechnology). The samples were loaded on pre-run (30 min, 100 V) 4% (30:1) polyacrylamide gels and run for 1 h at 150 V in 0.5 × TBE at room temperature. Gels were dried and exposed to Kodak XAR films at −80°C with an intensifying screen.
Apoptosis
For induction of apoptosis cells were cultured for 48 h in RPMI 1640 medium supplemented with 0.1% FBS with or without addition of SB203580 (1 M), PD98059 (10 M), or IL1 (100 U/ml). Cell death was assessed by acridine orange/ethidium bromide staining as described by Duke and Cohen. 35 Apoptotic/dead cells showed pronounced membrane blebbing, often fragmented, condensed nuclei and, in later stages, loss of membrane integrity. Apoptosis was also assessed by the TUNEL (terminal deoxynucleotidyltransferasemediated dUTP-biotin nick end labeling) assay (Boehringer). After 24 h of incubation, 2 × 10 6 cells were washed twice in PBS/1% BSA and resuspended in 100 l PBS. Subsequently, 100 l of paraformaldehyde solution (4% in PBS pH 7.4) was added to the cell suspension and fixation was performed for 30 min at room temperature. Cells were washed twice with PBS/1% BSA and subsequently permeabilized in 100 l PBS/0.2% Tween-20 for 15 min at 37°C. After washing twice with PBS/1% BSA, the cells were resuspended in 25 l TUNEL reaction mixture and incubated for 45 min at 37°C. Subsequently, the cells were washed twice in PBS/1% BSA and the amount of apoptotic cells was determined by FACS analysis (FACStar, Becton Dickinson, San Jose CA, USA).
Statistical analysis
The Student's t-test for paired samples was used to determine significance of the apoptosis data.
Results
Growth factor deprivation and IL-1 both induce JNK and p38 activation but show opposite effects on ERK activity
Activation of the JNK and p38 signal transduction pathways plays a role in both cell activation and apoptosis, but the mechanism by which these activated kinases mediate these antagonistic responses are presently unclear. To analyze further the apparent counteracting functions of JNK and p38, we examined the effects of growth factor deprivation (apoptosis) and exposure to IL-1 (cell activation) on the activity of the different kinases. Deprivation of TF-1 cells of either FBS or IL-3 resulted in a slight increase in the percentage of apoptotic cells (data not shown). Subsequently, TF-1 cells in the exponential phase of their growth were deprived of IL-3 and cultured in 0.1% FBS to induce a significant number of apoptotic cells. We first measured the activity of JNK and p38 kinases by in vitro kinase assays. TF-1 cells that grow under optimal conditions show low basal levels of JNK activity (Figure 1a) . Immediately upon growth factor deprivation, JNK activity was increased and reached a 4.3-fold increase after 48 h in three independent experiments (Figure 1a) . Similar results were obtained for p38. A 2.8-fold increase in activity after 48 h of growth factor deprivation was observed in three independent experiments (Figure 1b) . To examine the effect of IL-1, TF-1 cells cultured overnight in 0.1% FBS were subsequently activated with IL-1 for 15 min. As shown in Figure 2 , unstimulated cells already showed low constitutive JNK activity. IL-1 enhanced JNK activity 2.4-fold, whereas p38 activity was upregulated 2.7-fold.
Next, we used the myelin basic protein (MBP) in vitro kinase assay to study the activity of ERK in TF-1 cells under the different experimental conditions. As shown in Figure 3a , ERK1 activity was present at start conditions. Immediately upon growth factor deprivation ERK1 activity decreased to 79% compared to cells grown under optimal conditions in three independent experiments. To study the effects of IL-1 on ERK kinase activity, cells were cultured overnight in 0.1% FBS and subsequently stimulated with IL-1 for 15 min. As shown in
Figure 1
In vitro kinase activity of JNK and p38 during growth factor deprivation. TF-1 cells were cultured in growth medium (C) or in RPMI 1640 supplemented with 0.1% FBS for the indicated periods of time. After lysis, samples were normalized for protein content, JNK (a) and p38 (b) were immunoprecipitated and their activity was determined by in vitro kinase assay using GST-cJun and GST-ATF-2, respectively, as substrates. Phosphorylated substrates were visualized by autoradiography. The amount of protein was determined by Western blotting.
Figure 2
Effect of IL-1 on the in vitro kinase activity of JNK and p38. Prior to stimulation TF-1 cells were cultured overnight in RPMI 1640 supplemented with 0.1% FBS. Cells were subsequently stimulated with medium (0), IL-1 (100 U/ml) or Anisomycin (10 g/ml) (as positive control) for 15 min. After lysis, samples were normalized for protein content, JNK and p38 were immunoprecipitated and their activity was determined by in vitro kinase assay. Phosphorylated substrates were visualized by autoradiography. The amount of protein was the same in each lane (not shown). 
IL-1 and the p38-inhibitor SB203580 protect TF-1 cells from apoptosis
To study further the dual role of p38 during apoptosis and IL-1 stimulation we investigated whether SB203580, which is a specific inhibitor of p38 activity, 32 can modulate the apoptotic process or the IL-1-mediated effects. To accomplish apoptosis, TF-1 cells in the exponential phase of their growth were cultured in 0.1% FBS in the absence or presence of SB203580 and IL-1. At several time points the percentage of apoptotic cells was determined by acridine orange staining and the TUNEL assay.
Firstly, with acridine orange staining, after 48 h a significant increase in the percentage of dead cells (2 ± 0.4% (x ± s.d., n = 3) vs 20 ± 5% (P Ͻ 0.05)) was observed (Figure 4a ). In the presence of SB203580, the increase in the percentage of dead cells was significantly less (20 ± 5% vs 11 ± 2% (P Ͻ 0.05)). Comparable results were obtained with IL-1 (10 ± 3% (P Ͻ 0.05)). The combination of IL-1 and SB203580 demonstrated an even more pronounced effect on the percentage of dead cells (7 ± 1%).
To investigate whether the ERK1/2 pathway plays a role in the anti-apoptotic effect of SB203580 and IL-1, cells were incubated with PD98059 which is a specific inhibitor of MEK1, 36 the upstream kinase of ERK1/2, in the absence and presence of IL-1 and/or SB203580. The results demonstrate that the addition of PD98059 drastically enhanced the per-
Figure 3
Effect of growth factor deprivation and IL-1 on the ERK in vitro kinase activity. (a) TF-1 cells were cultured in growth medium (C) or in 0.1% FBS for the indicated periods of time. After lysis, samples were normalized for protein content, ERK1 was immunoprecipitated and its activity was determined by in vitro kinase assay using myelin basic protein as substrate. The amount of protein was determined by Western blotting. (b) Prior to stimulation TF-1 cells were cultured overnight in RPMI 1640 supplemented with 0.1% FBS. Cells were subsequently stimulated with medium (0), IL-1 (100 U/ml) or PMA (50 ng/ml) (as positive control) for 15 min. ERK1 was immunoprecipitated and its activity was determined by in vitro kinase assay using Myelin Basic Protein (MBP) as a substrate. Phosphorylated substrate was visualized by autoradiography. The amount of protein was the same in each lane (not shown).
centage of dead cells, resulting in a two-fold increase compared to cells cultured in 0.1% FBS. The addition of PD98059 in the presence of IL-1 resulted in a 2.5-fold increase of dead cells compared to cells stimulated with IL-1 alone (Figure 4b ). This PD98059-mediated increase of dead cells in the presence of IL-1 could partially be counteracted by the addition of SB203580, resulting in a two-fold increase of dead cells.
Quantitation of apoptosis determined by the TUNEL assay after 24 h of incubation showed a similar pattern under the different experimental conditions. TUNEL labeling demonstrated that in the presence of either SB203580 or IL-1 the percentage of apoptotic cells was significantly less compared to cells cultured in 0.1% FBS; SB203580 reduced the percent of apoptotic cells by 33 ± 14% and IL-1 by 53 ± 14% (n = 3, P Ͻ 0.05). As observed with the acridine orange staining, the addition of PD98059 resulted in a 1.5-fold increase of apoptotic cells compared to cells cultured in 0.1% FBS.
The specificity of SB203580 and PD98059 was confirmed by examining their effect on the IL-1-induced activity of the p38 and ERK kinases. TF-1 cells were cultured overnight in 0.1% FBS, pre-incubated for 30 min with SB203580 or PD98059 and subsequently stimulated for 15 min with IL-1. As shown in Figure 5 , the IL-1-induced p38 activity was strongly inhibited by SB203580 to 54% whereas the ERK activity was suppressed by PD98059 to 62%, with respect to their activities measured in the absence of the inhibitors.
The Shc/Ras/ERK pathway protects cells from apoptosis
Since the IL-1-induced upregulation of ERK activity seems to play an important role in the protection against apoptosis, we examined in more detail the protective function of the ERK signaling pathway in the apoptotic process. Therefore, we studied the effects of growth factor deprivation in a cell line (TF-1-SHC) that was stably transfected with and overexpresses the Shc protein, a protein upstream of the MEK/ERK pathway. 33 Overexpression of the Shc protein results in the activation of the ERK pathway. The effects of growth factor deprivation on TF-1-Shc cells were compared with control cells transfected with an empty vector (TF-1-SN). First, we examined whether the overexpression of Shc modulates the apoptotic process. TF-1-SN cells demonstrated a significant increase in the percentage of apoptotic cells after 48 h of culture in 0.1% FBS (31 ± 13% vs 2 ± 1% (x ± s.d., n = 6, P Ͻ 0.05)). In contrast, TF-1-SHC cells showed a distinct survival advantage during the period of observation (15 ± 9% apoptotic SHC cells vs 31 ± 13% apoptotic SN cells (n = 6, P Ͻ 0.05)). The percentage of apoptotic SHC cells could not be modulated by PD98059 (15 ± 9% without inhibitor vs 15 ± 7% plus PD98059 (P Ͻ 0.8) or SB203580 (15 ± 9% vs 13 ± 8% (P Ͻ 0.2)) after 48 h. Next we were interested in whether the overexpression of Shc and the coincided advantage in survival were related to a higher ERK activity. As shown in Figure 6 , TF-1-SHC cells did express a high amount of SHC protein at a continuous level during the period of observation. In contrast to TF-1-SHC cells, TF-1-SN cells expressed SHC at a non-detectable endogenous level. During growth factor deprivation ERK activity decreased strongly in the TF-1-SN cells ( Figure 6 ). TF-1-SHC cells demonstrated a much higher ERK activity (3.4-fold) at start which did decrease during growth factor deprivation but the overall ERK activity was significantly higher than in TF-1-SN cells, whereby the amounts of ERK protein were of equal proportions in both cell lines.
Growth factor deprivation and IL-1 have opposite effects on transcription factor binding activities
The transcription factors NF-B and AP-1 play a critical role in cell survival and proliferation. [37] [38] [39] To further explore the effects of growth factor deprivation and IL-1 stimulation on intracellular signaling pathways, we examined their effects on DNA binding activity of the transcription factors NF-B and AP-1 by EMSA. TF-1 cells that were cultured under optimal conditions showed a constitutive binding activity of the transcription factors NF-B and AP-1 ( Figure 7) . Upon growth factor deprivation, DNA binding activity of both transcription factors decreased rapidly. In contrast, TF-1 cells that were treated with IL-1 showed a marked increase in NF-B and AP-1 binding activity (Figure 7) . Specificity of NF-B and AP-1 binding was demonstrated by adding a 100-fold molar excess of unlabeled self or non-self probe and by supershift experiments with antibodies against NF-B p50 and p65 (Figure 7) .
In the next set of experiments we questioned whether blocking of p38 activity modulates the binding activity of the transcription factors NF-B and AP-1. As shown in Figure 7 , the decrease in NF-B DNA binding activity was much less pronounced in the presence of SB203580 (2.1-fold more NF-B binding compared to 0.1% FBS) and IL1 (4.5-fold) after 48 h in three independent experiments. The combination of IL1 plus SB203580 had an even stronger effect, resulting in a NF-B DNA binding activity that was 5.8-fold stronger compared to 0.1% FBS. The same results were observed for AP-1 binding activity (Figure 7) . In contrast, addition of PD98059 counteracts the effects of IL-1 and SB203580 on the DNA binding activity of NF-B and AP-1, resulting in a 2-6-fold decrease compared to cells stimulated with SB203580 or IL-1 alone (Figure 8) .
To further examine the function of the ERK pathway in modulating NF-B DNA binding activity, we investigated the effect of PD98059 on the NF-B DNA binding activity of TF-1-SHC
Figure 5
Effects of SB203580 and PD98059 on the IL-1-induced p38 and ERK kinase activity. Prior to stimulation TF-1 cells were cultured overnight in RPMI 1640 supplemented with 0.1% FBS. Cells were subsequently stimulated with medium (0), IL-1 (100 U/ml), IL-1 plus SB203580 or IL-1 plus PD98059. After lysis, samples were normalized for protein content, p38 and ERK were immunoprecipitated and their activity was determined by in vitro kinase assay. Phosphorylated substrates were visualized by autoradiography. The amount of protein was the same in each lane (not shown).
Figure 6
In vitro ERK kinase activity during growth factor deprivation of TF-1-SHC and SN cells. TF-1-SHC and SN cells were cultured in growth medium (C) or in RPMI 1640 supplemented with 0.1% FBS for the indicated periods of time. After lysis, samples were normalized for protein content, ERK1 was immunoprecipitated and its activity was determined by in vitro kinase assay using MBP as substrate. Phosphorylated substrate was visualized by autoradiography. The amount of ERK, SHC and actin protein was determined by Western blotting. cells during growth factor deprivation. As demonstrated in Figure 9 , TF-1-SHC cells demonstrated constitutive NF-B DNA binding activity under optimal conditions. Upon growth factor deprivation, NF-B DNA binding decreased but not as strongly as in wild-type TF-1 cells. Addition of PD98059 did not result in a substantial decrease of NF-B DNA binding activity of TF-1-SHC cells during growth factor deprivation.
Discussion
The phenomena of cell survival and apoptosis involve a highly regulated process in which p38 seems to have a crucial function. 15, 24 The present study demonstrates that growth factor deprivation of hematopoietic cells is associated with enhanced p38/JNK activity and decreased activity of ERKs. The enhanced activity of p38 fulfills an important role since the p38 inhibitor SB203580 can interrupt the ongoing process of apoptosis. This interruption of apoptosis is associated with an increased AP-1 and NF-B binding activity. Recently, a similar effect of SB203580 was observed on the sodium salicylate-induced apoptosis in fibroblasts. 40 Intriguingly, the enhanced cell survival due to IL-1 exposure is also associated with an increase in p38 activity. This coincides with an increase of ERK activity and an increase in binding activity of AP-1 and NF-B. However, the observed increase in p38 activity in response to IL-1 stimulation seems not to be crucial for the IL-1-mediated cell survival since blocking of the p38 function by SB203580 further repressed the apoptotic process. This might imply that the function of additional SAPKs are relatively increased since SB203580 inhibits p38 selectively without affecting the function of JNK or ERK6. 32 Alternatively, SB203580 might favor the balance between ERKs and SAPKs signaling routes to the ERK pathway. This is supported by the finding that PD98059, a specific blocker of the ERK pathway, 36 inhibited the suppressive effects of SB203580 and IL-1 on the apoptotic process which provides evidence that the ERK pathway is crucial for cell survival. Additional evidence for the importance of the ERK pathway is supported by data demonstrating that TF-1 cells overexpressing the SHC protein survived longer, which coincided with a higher ERK activity during the period of growth factor deprivation. The observation that PD98059 had no substantial effect on the NF-B DNA binding activity and percentage of apoptotic cells of the TF-1-SHC cell line might be explained by the fact that due to the overexpression of the SHC protein additional signaling pathways may be triggered. Blocking of the ERK pathway by PD98059 might result in a switch to and activation of these pathways. The additional activated signaling molecules will then enhance NF-B DNA binding and thus survival of the cells.
The IL-1 and SB203580-mediated effects were also associa-
Figure 7
Effects of SB203580 and IL-1 on the binding activity of AP-1 and NF-B. TF-1 cells were cultured for 48 h in growth medium (C), in RPMI 1640 medium supplemented with 0.1% FBS, with SB203580 (1 M), IL-1 (100 U/ml) or SB203580 plus IL-1. Nuclear extracts were prepared, normalized for protein content, and AP-1 and NF-B binding activity was determined using an electrophoretic mobility shift assay (EMSA). Specificity of NF-B and AP-1 binding was determined by adding a 100-fold molar excess of unlabeled NF-B or AP-1 probe and by supershift experiments with antibodies against NF-B p50 and p65.
ted with enhanced NF-B binding activity. The higher levels of NF-B might have a critical function in the protection against apoptosis. Liu et al 37 have shown that transfection of Hela cells with an expression vector for the NF-B subunits c-Rel or p65 protected the cells against TNF␣-induced apoptosis. The upregulation of NF-B in our experiments may favor cell survival and seems not to be mediated by the p38 route as was demonstrated for TNF␣ (Beyaert et al) . 16 Our results can not discriminate whether IL-1 and SB203580 act by attenuating or delaying the process of ongoing apoptosis. In this respect, future studies may reveal the exact role of NF-B in anti-apoptotic signaling in TF-1 leukemic cells.
The exact role of AP-1 in the apoptotic process is not well defined. In the present study we demonstrate that the ongoing apoptotic process was associated with a decrease in the DNA binding activity of AP-1, which could partially be blocked by the p38 blocker SB203580. The composition of AP-1 is dependent on the formation of homo-or hetero-dimers of the Fos and Jun families, whereby Jun has an important role. 41 Recently, different studies have shown that enhanced expression of c-jun is a pre-requisite for the apoptotic process. [42] [43] [44] However, the enhanced expression of c-jun in these cases is not associated with an increase in the DNA binding of AP-1. 43 The increase in c-jun expression might be due to enhanced phosphorylation of JNK, a kinase upstream of cJun, 4 which increases in time during growth factor depri-
Figure 8
Effect of PD98059 on the binding activity of AP-1 and NF-B. TF-1 cells were cultured for 48 h in RPMI 1640 medium supplemented with 0.1% FBS, with SB203580 (1 M), SB203580 plus PD98059 (10 M), IL-1 (100 U/ml) or IL-1 plus PD98059. Nuclear extracts were prepared, normalized for protein content and AP-1 and NF-B binding activity was determined using electrophoretic mobility shift assay (EMSA).
Figure 9
Effect of PD98059 on the NF-B binding activity of TF-1-SHC cells. TF-1-SHC cells were cultured for 48 h in growth medium (C), in RPMI 1640 medium supplemented with 0.1% FBS, or 0.1% FBS with PD98059 (10 M). Nuclear extracts were prepared, normalized for protein content and NF-B binding activity was determined using EMSA.
vation. Due to the increased JNK activity and the concomitant c-jun expression, an increase in AP-1 binding activity during apoptosis would be expected. However, we observed that the AP-1 binding did not correlate with JNK activity but instead correlates with the apoptotic process. The discrepancy might be ascribed to the fact that the half-life of c-Jun is short, 45 and that during the apoptotic process protein degradation predominates the de novo protein synthesis resulting in an overall decrease of AP-1 protein. Furthermore, it is not well defined to what extent the JNK signaling pathway is actually involved in apoptosis. The reports concerning JNK involvement in apoptosis are contradictory. Recently, it has been reported that apoptotic cell death is driven by the activation of caspase proteases which may act up or downstream of JNK. [26] [27] [28] [29] Apoptosis induced by activated Cdc42 could be blocked by dominant negative mutants of the JNK cascade and specific caspase inhibitors, suggesting that the JNK cascade activates caspases. 27 Furthermore, caspases can induce apoptosis by cleaving and activating MEKK-1, an upstream activator of JNK, which in turn activates more caspase activity. 26 So in our system the enhanced JNK activity may more likely affect the apoptotic process by activation of caspases and not via the activation of AP-1. However, some reports demonstrated that JNK activity is not sufficient for apoptosis. It has been demonstrated that the JNK pathway is not involved in the TNF␣ induced apoptosis. 37 In addition, in Fas-induced apoptosis no induction of AP-1 or an AP-1 responsive reporter was observed despite the fact that JNK was activated. 46 However, Yang et al 47 recently demonstrated that MKK4, an upstream activator of JNK, seems to have a critical function for AP-1 transcriptional activity since cultured homozygous MKK4 knockout (MKK4(−/−) ES cells were defective in the activation of JNK and AP-1 dependent reporter gene expression. 47 In summary, our data demonstrate a dual function of the p38 pathway in cell activation and apoptosis whereby other factors determine the final cellular response. The finding that ERK activity and NF-B binding activity are upregulated by the survival factor IL-1 and that the ERK pathway is crucial for the cell survival might be an indication that the ERK kinase is one of these factors.
